Trump signs executive order to lower drug prices, including provisions for reducing insulin costs and aligning Medicare drug price negotiations.
Cuomo's NYC mayoral campaign hit with $4M public funds denial due to technical errors, but remains a frontrunner with significant private fundraising and union support.
J&J beats Q1 expectations, maintains FY 2025 outlook despite Stelara sales decline and medtech underperformance.
Trump signs executive order to lower drug prices, including provisions for reducing insulin costs and aligning Medicare drug price negotiations.
Cuomo's NYC mayoral campaign hit with $4M public funds denial due to technical errors, but remains a frontrunner with significant private fundraising and union support.
J&J beats Q1 expectations, maintains FY 2025 outlook despite Stelara sales decline and medtech underperformance.